EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Geriatric Assessment in Oncology: Evolution, Evidence, and Implications for Geriatric Medicine in Japan

Hiroshi Yamamoto iD, Namio Kagoo iD, Ho Lee iD, Manami Sazuka iD, Chiemi Nogimori iD, Hirokazu Yamada iD, Akira Saito iD

Geriatrics & Gerontology International · 2026-03 · 26 (3)

DOI: 10.1111/ggi.70433 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 09.03.2026. Verfasst von Hiroshi Yamamoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan. Hauptthemen laut MEDLINE: Geriatric Assessment, Geriatrics, Medical Oncology, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review summarizes the evolution of recommendations for geriatric assessment (GA), the randomized evidence underpinning GA‐guided management (GAM), and current implementation challenges in Japan. From the combined perspectives of oncology and geriatric medicine, we discuss how GA relates to comprehensive geriatric assessment (CGA), and argue that GA is best understood as an oncology‐adapted extension of CGA. Recent trials show that active, multidisciplinary implementation of GA is associated with improvements in treatment toxicity, functional status, communication, and quality of life. In Japan, GA remains underused because of workforce limitations and structural barriers, despite its conceptual fit with the national long‐term care insurance (LTCI) system. Progress will require practical workflows that link assessment to management, selective integration of GA with LTCI information to reduce duplication, and sustained collaboration between oncology and geriatrics. Overall, GA has moved beyond risk stratification toward a pragmatic, evidence‐supported approach that may help reframe cancer care for older adults in Japan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Geriatric AssessmentGeriatricsMedical OncologyNeoplasmsHumansJapanAgedQuality of Life

Stichwörter der Autor:innen

cancer in older adultscomprehensive geriatric assessmentgeriatric assessmentgeriatric oncologymultidisciplinary care

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.

ORCID-Profile: Hiroshi Yamamoto, Namio Kagoo, Ho Lee, Manami Sazuka, Chiemi Nogimori, Hirokazu Yamada, Akira Saito

Zitieren

APA

Yamamoto, H., Kagoo, N., Lee, H., Sazuka, M., Nogimori, C., Yamada, H., & Saito, A. (2026). Geriatric Assessment in Oncology: Evolution, Evidence, and Implications for Geriatric Medicine in Japan. Geriatrics & Gerontology International, 26(3). https://doi.org/10.1111/ggi.70433

Vancouver

Yamamoto H, Kagoo N, Lee H, Sazuka M, Nogimori C, Yamada H, et al. Geriatric Assessment in Oncology: Evolution, Evidence, and Implications for Geriatric Medicine in Japan. Geriatrics & Gerontology International. 2026;26(3). doi:10.1111/ggi.70433

BibTeX
@article{Yamamoto2026,
  author = {Yamamoto, Hiroshi and Kagoo, Namio and Lee, Ho and Sazuka, Manami and Nogimori, Chiemi and Yamada, Hirokazu and Saito, Akira},
  title = {Geriatric Assessment in Oncology: Evolution, Evidence, and Implications for Geriatric Medicine in Japan},
  journal = {Geriatrics & Gerontology International},
  year = {2026},
  volume = {26},
  number = {3},
  doi = {10.1111/ggi.70433}
}
Kostenlos starten →